Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tg Therapeutics (TGTX) Tax Provisions: 2023-2025

Historic Tax Provisions for Tg Therapeutics (TGTX) over the last 2 years, with Sep 2025 value amounting to -$365.0 million.

  • Tg Therapeutics' Tax Provisions fell 91350.00% to -$365.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$359.7 million, marking a year-over-year decrease of 73368.43%. This contributed to the annual value of $2.2 million for FY2024, which is 466.92% up from last year.
  • As of Q3 2025, Tg Therapeutics' Tax Provisions stood at -$365.0 million, which was down 13,455.29% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, Tg Therapeutics' Tax Provisions ranged from a high of $2.7 million in Q2 2025 and a low of -$365.0 million during Q3 2025.
  • Its 3-year average for Tax Provisions is -$44.9 million, with a median of $395,000 in 2023.
  • Examining YoY changes over the last 5 years, Tg Therapeutics' Tax Provisions showed a top increase of 1,306.90% in 2025 and a maximum decrease of 91,350.00% in 2025.
  • Quarterly analysis of 3 years shows Tg Therapeutics' Tax Provisions stood at $390,000 in 2023, then skyrocketed by 441.28% to $2.1 million in 2024, then tumbled by 91,350.00% to -$365.0 million in 2025.
  • Its Tax Provisions stands at -$365.0 million for Q3 2025, versus $2.7 million for Q2 2025 and $408,000 for Q1 2025.